SYK vs ISRG
SYK and ISRG side by side — valuation & fundamentals (public data).
Key statistics
| Metric | SYKSTRYKER CORP | ISRGIntuitive Surgical, Inc. |
|---|---|---|
| Market cap | $116.86B | $151.37B |
| P/E (TTM) | 32.7 | 52.8 |
| P/B | 9.96 | 9.47 |
| P/S | 4.6x | 15.1x |
| Dividend yield | 1.10% | — |
| Revenue | $26.30B(TTM) | $11.58B(TTM) |
| Revenue growth (YoY) | 11.2% | 20.5% |
| Net income | $3.62B(TTM) | $2.96B(TTM) |
| Earnings growth (YoY) | 8.5% | 23.0% |
| EPS, diluted | $9.39(TTM) | $8.27(TTM) |
| EBIT margin | 19.5% | 29.3% |
| ROE | 27.7% | 17.9% |
| ROIC | 15.0% | — |
| Piotroski F | 9/9 | — |
| 1y total return | -14.7% | -18.1% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: SYK vs ISRG
| Metric | SYK | ISRG |
|---|---|---|
| End value | $28.6K | $59.4K |
| Total return | +186.2% | +494.5% |
| CAGR | +10.7% | +18.8% |
| Volatility | 27.0% | 32.8% |
| Sharpe | 0.36 | 0.56 |
| Sortino | 0.51 | 0.81 |
| Max drawdown | -43.8% | -49.9% |
Based on 2600 common trading days, 2016-06-30 → 2026-11-02 · risk-free 4.21% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)